You are here

Article info

Article menu
Clinical/translational cancer immunotherapy
Original research
Elicitation of stem-like CD8+ T cell responses via lymph node-targeted chemoimmunotherapy evokes systemic tumor control

Authors

  • Margaret P Manspeaker Parker H. Petit Institute of Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, Georgia, USASchool of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA PubMed articlesGoogle scholar articles
  • Meghan J O'Melia Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia, USA PubMed articlesGoogle scholar articles
  • Susan N Thomas Parker H. Petit Institute of Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, Georgia, USAWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia, USAGeorge W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia, USAWinship Cancer Institute, Emory University, Atlanta, Georgia, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Susan N Thomas; susan.thomas{at}gatech.edu
View Full Text

Citation

Manspeaker MP, O'Melia MJ, Thomas SN
Elicitation of stem-like CD8+ T cell responses via lymph node-targeted chemoimmunotherapy evokes systemic tumor control
Journal for ImmunoTherapy of Cancer 2022;10:e005079. doi: 10.1136/jitc-2022-005079

Publication history

  • Accepted August 16, 2022
  • First published September 13, 2022.
Online issue publication 
September 13, 2022

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.